Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
12/16/1999 | CA2315883A1 Muscarinic receptor antagonists |
12/16/1999 | CA2299678A1 Tgf.beta. rii receptor nucleic sequence, coded peptide, and uses |
12/16/1999 | CA2293694A1 New carboxypeptidase inhibitor |
12/15/1999 | EP0963999A1 E2f activity inhibitory compounds |
12/15/1999 | EP0963441A1 Inactivation of hiv co-receptors as therapy for hiv infection |
12/15/1999 | EP0963440A1 Improved methods for transducing cells |
12/15/1999 | EP0963437A1 The process for the expression and production of the recombinant human beta-cis interferon |
12/15/1999 | EP0963436A1 Nucleic acid encoding congenital heart disease protein and products related thereto |
12/15/1999 | EP0963434A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection |
12/15/1999 | EP0963433A1 Transgenic plants expressing geminivirus genes |
12/15/1999 | EP0963431A1 NOVEL FabH |
12/15/1999 | EP0963377A1 Interleukin-19 |
12/15/1999 | EP0963208A1 INHIBITION OF Ii SYNTHESIS |
12/15/1999 | EP0963207A1 Il-12 gene therapy of tumors |
12/15/1999 | EP0963205A1 T1 receptor-like ligand ii |
12/15/1999 | EP0963203A2 Mammalian tolloid-like gene and protein |
12/15/1999 | EP0963197A1 Guanylhydrazones useful for treating diseases associated with t cell activation |
12/15/1999 | EP0963196A2 Hyaluronic drug delivery system |
12/15/1999 | EP0695307B1 Modified protein and peptide pharmaceuticals |
12/15/1999 | EP0668912B1 THE St-B17 SEROTONIN RECEPTOR |
12/15/1999 | EP0643585B1 The use of Lipoprotein Associated Coagulation Inhibitor (LACI) for the preparation of a medicament for the treatment of acute or chronic inflammation. |
12/15/1999 | EP0631505B1 Use of a peptide |
12/15/1999 | EP0584283B1 Osteoinductive protein mixtures and purification processes |
12/15/1999 | EP0567567B1 A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS |
12/15/1999 | EP0414730B1 Chemical Compounds and pharmaceutical compositions capable of releasing a drug |
12/15/1999 | CN1238783A Method and novel compounds for use therein |
12/15/1999 | CN1238782A Colostrinin and uses thereof |
12/15/1999 | CN1238781A Heptapeptide oxytocin analofues |
12/15/1999 | CN1238780A Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
12/15/1999 | CN1238779A Method and compounds for inhibiting 'beta'-amyloid peptide release and/or synthesis |
12/15/1999 | CN1238697A Use of melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype |
12/15/1999 | CN1238693A Pharmaceutical composition comprising compound having anti-Xa activity and platelet aggregation antagonist compound |
12/15/1999 | CN1238217A Medicinal composition of polypeptide for treating radiation damage |
12/15/1999 | CN1238216A Oral immunity enhancing agent |
12/15/1999 | CN1238184A Method for raising pigs and promoting them stronger |
12/15/1999 | CN1047402C Process for producing synthetic gene of encoding polyporus seed storage albumen |
12/15/1999 | CA2274365A1 Compounds and compositions containing them useful for the transfer of active substances into a cell |
12/14/1999 | US6001991 Antisense oligonucleotide modulation of MDR P-glycoprotein gene expression |
12/14/1999 | US6001989 Nucleotide based endonucleases |
12/14/1999 | US6001988 High affinity nucleic acid ligands to lectins |
12/14/1999 | US6001987 Isolated nucleotide sequences associated with Multiple sclerosis |
12/14/1999 | US6001985 Fusion protein delivery systems and uses thereof |
12/14/1999 | US6001977 Antibody produced by immunizing an animal with an immunoreactive polypeptide from the envelope domain of human immunodeficiency virus; for diagnostic immunoassays and neutralizing antibodies |
12/14/1999 | US6001973 Antagonists of interleukin-15 |
12/14/1999 | US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor |
12/14/1999 | US6001971 Human transcription factor |
12/14/1999 | US6001970 Modified human neuropeptide Y1 Receptors |
12/14/1999 | US6001969 Recombinant TGF-β type II receptor polypeptides |
12/14/1999 | US6001968 Mammalian obese polypeptide; for use in genetic therapy; for the treatment of mammals to control body weight and fat content in mammals; for the detection of modulators of weight control |
12/14/1999 | US6001967 Herpes virus proteinase and method of assaying |
12/14/1999 | US6001965 Human pentapeptide used for testing tumor cells capable of metastases; anticarcinogenic agents; antitumor agents; antiproliferative agents |
12/14/1999 | US6001963 Human neuron receptor binding polypeptide which can play a role in treating, preventing, or reducing effects of diseases; for identifying modulators of the activity of the binding polypeptide; anticarcinogenic agents |
12/14/1999 | US6001962 Adjusted polypeptide which binds to cell surface receptor and activates apoptic response; for in vitro and in situ models that screen for modulators of the cell surface receptors; for treatment of autoimmune, liver, and apoptosis defects |
12/14/1999 | US6001961 Cyclic adhesion inhibitors |
12/14/1999 | US6001960 Small cyclic peptides which are more stable than endogenous cyclic peptides in the human body and can be used as affinity ligands for g-protein-linked receptors |
12/14/1999 | US6001884 (substituted phenylene)alkylaminealkyl phenylene compounds of given formula; administering to treat disorders characterized by abnormal calcium homeostasis such as hyperparathyroidism, paget's disease, osteoporosis and hypertension |
12/14/1999 | US6001823 Novel pyranosides which are believed to be capable of interacting with periplasmic molecular chaperones |
12/14/1999 | US6001816 Gene therapy for leptin deficiency |
12/14/1999 | US6001815 Depsipeptides containing N-substituted glycine residue |
12/14/1999 | US6001814 Serine protease inhibitors |
12/14/1999 | US6001813 Val-pro containing α-keto oxadiazoles as serine protease inhibitors |
12/14/1999 | US6001812 Modulating body/cranial hair growth with derivatives of the α-type melanocyte-stimulating hormone |
12/14/1999 | US6001811 Serine protease inhibitors--N-substituted derivatives |
12/14/1999 | US6001810 Methods for treating retroviral infection |
12/14/1999 | US6001809 Peptide having specified amino acid sequence; antiinflammatory agents, in particular for brain disorders |
12/14/1999 | US6001808 Administering effective amount of gramicidin for therapy and prevention |
12/14/1999 | US6001806 Aministering to patients in need of elevated levels of interferon, drugs selected from polypepides of specified amino acid sequences and a carrier |
12/14/1999 | US6001805 Administering composition containing fibroblast andkerotinocyte proliferatingly effective amount of antimicrobially effective ampioathic peptide having specified amino acid sequences |
12/14/1999 | US6001804 Method of blocking human islet cell immunoglobulin andlymphocytes by contacting them with a polypeptide comprisngspecified amino acid sequences |
12/14/1999 | US6001803 Effecive to expand and differentiate progenitor cells into dendriti cells |
12/14/1999 | US6001802 Antiproliferative agents |
12/14/1999 | US6001801 Administering antidiabetic agent cyclic peptide to inhibit insulin release in patient |
12/14/1999 | US6001800 Atomizing into hot air an aqueous solution of recombitant human erythropoietin to evapororate sprayed particles to dryness, separating |
12/14/1999 | US6001799 Method of treating hepatitis C in non-responders to interferon treatment |
12/14/1999 | US6001653 Human type 2 RNase H |
12/14/1999 | US6001652 Antisense modulation of cREL expression |
12/14/1999 | US6001651 Antisense modulation of LFA-3 |
12/14/1999 | US6001649 Chemokine NC28 (monocyte chemotactic protein-3, MCP-3) polypeptides and their recombinant production |
12/14/1999 | US6001648 Optimized minizymes and miniribozymes and uses thereof |
12/14/1999 | US6001632 Human protein disulfide isomerase |
12/14/1999 | US6001630 Hydrolase/lyase enzyme isolated from microorganism; for curing intervertebral disc displacement |
12/14/1999 | US6001624 Mitochondrial adenylate kinase |
12/14/1999 | US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease |
12/14/1999 | US6001622 Integrin-linked kinase and its use |
12/14/1999 | US6001621 Protein tyrosine kinases |
12/14/1999 | US6001620 Amino acid sequence of enzyme; for diagnosis, prevention and treatment of autoimmune disorders and cancer; anticarcinogenic agents |
12/14/1999 | US6001618 Haloacetoacetate reductase, method for producing said enzyme, and method for producing alcohols using said enzyme |
12/14/1999 | US6001606 Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby |
12/14/1999 | US6001605 Dna sequence coding for two cytokines; diagnosing human colon cancer; for detecting antiinflammatory agents |
12/14/1999 | US6001603 Polynucleotide sequence coding for a staphylococcus enzmatic protein; for diagnosis, treatment and prevention of bacterial infections; bactericides |
12/14/1999 | US6001602 DNA encoding Chlamydia trachomatis isoleucyl tRNA synthetase polypeptides |
12/14/1999 | US6001601 Methionyl tRNA synthetase polynucleotides |
12/14/1999 | US6001600 DNA encoding tests polypeptides |
12/14/1999 | US6001598 Two new human DnaJ-like proteins |
12/14/1999 | US6001596 Growth-associated protease inhibitor heavy chain precursor |
12/14/1999 | US6001594 Human testin |
12/14/1999 | US6001593 Polynucleotide sequence coding muscle fiber protein; for detecting a polynucleotide which codes muscle fiber protein in a sample; for treating or preventing immunological, fertility, and cell migration defects; antitumor agents |
12/14/1999 | US6001589 Selecting tumor, cancer, or cultured cells; cloning a portion of a nucleotide sequence which encodes a protein of interest; sequencing the cloned nucleotide sequence and predicting the amino acid sequence; comparing to non-diseased cells |
12/14/1999 | US6001584 Detecting a cell with terminal kinase activity; contacting a cell component associated with terminal kinase with antibody and detecting interaction; antiproliferative agents |
12/14/1999 | US6001575 Nucleic acid sequences coding glutamate receptor interacting protein; for detecting glutamate receptor in tissues and screening receptor modulating drugs; diagnosis and therapy for infertility, nervous system and memory defects |